Hatanaka KC - Search Results

1

Precision cancer genome testing needs proficiency testing involving all stakeholders.

Maekawa M, Taniguchi T, Nishio K, Sakai K, Matsushita K, Nakatani K, Ishige T, Ikejiri M, Nishihara H, Sunami K, Yatabe Y, Hatanaka KC, Hatanaka Y, Yamamoto Y, Fukuyama K, Oda S, Saito K, Yokomura M, Kubo Y, Sato H, Tanaka Y, Fuchioka M, Yamasaki T, Matsuda K, Kurachi K, Funai K, Baba S, Iwaizumi M. Maekawa M, et al. Among authors: hatanaka kc, hatanaka y. Sci Rep. 2022 Jan 27;12(1):1494. doi: 10.1038/s41598-022-05589-x. Sci Rep. 2022. PMID: 35087199 Free PMC article.

2

Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer.

Yoshioka T, Hosoda M, Yamamoto M, Taguchi K, Hatanaka KC, Takakuwa E, Hatanaka Y, Matsuno Y, Yamashita H. Yoshioka T, et al. Among authors: hatanaka kc, hatanaka y. Breast Cancer. 2015 Mar;22(2):185-91. doi: 10.1007/s12282-013-0474-2. Epub 2013 May 5. Breast Cancer. 2015. PMID: 23645542 Free article. Clinical Trial.

3

Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomography.

Domen H, Hida Y, Okamoto S, Hatanaka KC, Hatanaka Y, Kaga K, Tamaki N, Hirano S, Matsuno Y. Domen H, et al. Among authors: hatanaka kc, hatanaka y. Jpn J Clin Oncol. 2013 Sep;43(9):874-82. doi: 10.1093/jjco/hyt100. Epub 2013 Aug 2. Jpn J Clin Oncol. 2013. PMID: 23911772 Free article.

4

p53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors.

Yamamoto M, Hosoda M, Nakano K, Jia S, Hatanaka KC, Takakuwa E, Hatanaka Y, Matsuno Y, Yamashita H. Yamamoto M, et al. Among authors: hatanaka kc, hatanaka y. Cancer Sci. 2014 Jan;105(1):81-8. doi: 10.1111/cas.12302. Epub 2013 Nov 22. Cancer Sci. 2014. PMID: 24118529 Free PMC article.

5

Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.

Hosoda M, Yamamoto M, Nakano K, Hatanaka KC, Takakuwa E, Hatanaka Y, Matsuno Y, Yamashita H. Hosoda M, et al. Among authors: hatanaka kc, hatanaka y. Breast Cancer Res Treat. 2014 Apr;144(2):249-61. doi: 10.1007/s10549-014-2867-0. Epub 2014 Feb 19. Breast Cancer Res Treat. 2014. PMID: 24549642 Free article.

6

High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients.

Sato H, Hatanaka KC, Hatanaka Y, Hatakeyama H, Hashimoto A, Matsuno Y, Fukuda S, Sabe H. Sato H, et al. Among authors: hatanaka kc, hatanaka y. Cell Commun Signal. 2014 Mar 12;12:17. doi: 10.1186/1478-811X-12-17. Cell Commun Signal. 2014. PMID: 24621372 Free PMC article.

7

Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms.

Fujita H, Hatanaka Y, Sutoh Y, Suzuki Y, Oba K, Hatanaka KC, Mitsuhashi T, Otsuka N, Fugo K, Kasahara M, Matsuno Y. Fujita H, et al. Among authors: hatanaka kc, hatanaka y. J Histochem Cytochem. 2015 Mar;63(3):217-27. doi: 10.1369/0022155414563800. Epub 2014 Dec 3. J Histochem Cytochem. 2015. PMID: 25473094 Free PMC article.

8

Feasibility of Using an Enzymatically Activatable Fluorescence Probe for the Rapid Evaluation of Pancreatic Tissue Obtained Using Endoscopic Ultrasound-Guided Fine Needle Aspiration: a Pilot Study.

Kawakubo K, Ohnishi S, Hatanaka Y, Hatanaka KC, Hosono H, Kubota Y, Kamiya M, Kuwatani M, Kawakami H, Urano Y, Sakamoto N. Kawakubo K, et al. Among authors: hatanaka kc, hatanaka y. Mol Imaging Biol. 2016 Jun;18(3):463-71. doi: 10.1007/s11307-015-0898-5. Mol Imaging Biol. 2016. PMID: 26431952 Free article.

9

Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.

Naka T, Hatanaka Y, Marukawa K, Okada H, Hatanaka KC, Sakakibara-Konishi J, Oizumi S, Hida Y, Kaga K, Mitsuhashi T, Matsuno Y. Naka T, et al. Among authors: hatanaka kc, hatanaka y. Diagn Pathol. 2016 Apr 18;11:38. doi: 10.1186/s13000-016-0488-0. Diagn Pathol. 2016. PMID: 27091358 Free PMC article.

10

Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma.

Kato T, Lee D, Wu L, Patel P, Young AJ, Wada H, Hu HP, Ujiie H, Kaji M, Kano S, Matsuge S, Domen H, Kaga K, Matsui Y, Kanno H, Hatanaka Y, Hatanaka KC, Matsuno Y, de Perrot M, Yasufuku K. Kato T, et al. Among authors: hatanaka kc, hatanaka y. Int J Oncol. 2016 Aug;49(2):448-56. doi: 10.3892/ijo.2016.3566. Epub 2016 Jun 7. Int J Oncol. 2016. PMID: 27279560 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page